您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

蔡成枝醫師

消化性潰瘍疾病、胃腸蠕動疾病(胃食道逆流疾病,食道弛緩不能症)、胃幽門螺旋桿菌診治、內視鏡診治
  • 國語,英語,閩南語
  • 教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚紀念醫院 顧問級主治醫師(2023.10~至今)
    • 高雄長庚紀念醫院 副院長 (2022.07～至今)
    • 長庚大學 醫學系 兼任教授 (2020.04)
    • 高雄長庚紀念醫院 教授級主治醫師 (2015.07)
    • 台灣消化系醫學會 第十六屆會員資格審核委員會委員
    • 台灣微菌聯盟 第二屆常務監事(2023.04-2026.04)
    • 台灣胃腸神經與蠕動學會 第三屆理事 (2022.03-2025.03)
  • 學歷
    • 台北醫學院醫學系畢
  • 經歷
    • 高雄長庚紀念醫院 內科部部主任 (2020.07-2022.06)
    • 高雄長庚紀念醫院 內科部副部主任 （2019.07-2020.06)
    • 長庚大學 醫學系兼任副教授 (2015.02-2020.03)
    • 高雄長庚紀念醫院 胃腸肝膽科系副科系主任
    • 高雄長庚紀念醫院 胃腸肝膽科系胃腸科主任
    • 高雄長庚紀念醫院 胃腸肝膽科系主治醫師
    • 林口長庚醫院內科部胃腸肝膽科主治醫師
    • 林口長庚醫院內科部胃腸肝膽科研究員
    • 林口長庚醫院內科部住院醫師
    • 台灣微菌聯盟 第1屆常務監事(2020.03-2023.03)
    • 台灣消化系內視鏡醫學會 第7屆監事、第8屆理事、第10屆理事(2010.04-2016.04,2019.04-2022.04)
    • 台灣胃腸神經與蠕動學會 第1屆理事、第2屆理事(2016.08-2022.08)
  • 學會與認證
    • 台灣內科醫學會 內科專科醫師
    • 台灣內科醫學會 指導醫師
    • 台灣消化系醫學會 消化系內科專科醫師
    • 台灣消化系醫學會 指導醫師
    • 台灣消化系內視鏡醫學會 專科醫師
    • 台灣消化系內視鏡醫學會 指導醫師
    • 中華民國醫用超音波學會 超音波專業醫師
    • 中華民國醫用超音波學會 指導醫師
    • 重症專科醫師
  • 論文及期刊發表
    • Tai WC, Yang SC, Yao CC, Wu CK , Liu AC, Lee CH, Kuo YH, Chuah SK*, Liang CM*. The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naive Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial. Infect Dis Ther. 2023 May;12(5):1415-1427. (SCI)
      比較新的第一線幽門螺旋桿菌除菌治療效果—隨機試驗之台灣報告
    • Lin CY, Wu KL*, Yao CC, Tsai CE, Tai WC, Liang CM, Chou YP, Chuah SK*. Clinical characteristics and esophageal motility in Sjogren's syndrome: A single-center study in Taiwan. Adv Dig Med. 2021 Dec; 8(4):218-223. (台灣消化醫學雜誌)
      Sjogren症候群的臨床表徵和食道蠕動力學表現: 台灣一醫學中心研究報告
    • Lai WT#, Chiu SM#, Wu CK, Liang CM, Yang SH, Yao CC, Kuo CM, Lu LS*, Chiu YC, Wu KL, Tai WC, Chuah SK*. Incidence of interval colorectal cancer: A tertiary hospital report. Adv Dig Med. 2021 Sept.; 8(3): 172-177. (台灣消化醫學雜誌)
      南臺灣間隔性大腸直腸癌之發生率及危險因子
    • Yang SC, Wu CK, Tai WC, Liang CM, Yao CC, Wu KL, Hsu CN*, Chuah SK*. Risks of adverse events for users of proton-pump inhibitors plus aspirin or clopidogrel in patients with aspirin-related ulcer bleeding. J Gastroenterol Hepatol. 2021 Jul;36(7):1828-1835. (SCI)
      Aspirin引起上消化道潰瘍出血後，氫離子幫浦阻斷劑加上aspirin或clopidogrel 等抗血栓劑合併使用發生不良反應的風險評估
    • Hung KT, Yang SC, Wu CK, Wang HM, Yao CC, Liang CM*, Tai WC, Wu KL, Kuo YH, Lee CH, Chuah SK*. Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice. Infect Drug Resist. 2021 Mar.; 2021(14):1239-1246. (SCI)
      比較第一線不含BISMUTH的7天期幽門桿菌四合一療法，由ESOMEPRAZOLE或LANSOPRAZ OLE當基底對於幽門桿菌清除率的影響
    • Tai WC, Wu KL*, Chuah SK*. An update on endoscopic treatment for achalasia: From peroral endoscopic myotomy to endolumenal functional lumen imaging probe. Adv Dig Med. 2021 Mar;8:8–9. (EDITORIAL) (台灣消化醫學雜誌)
      結合下食道弛緩不能症舊的診斷和治療的及新進展-綜論
    • Liang CM, Tai WC, Hsu PI, Wu DC, Kuo CH, Tsay FW, Lee CL, Chen KY*, Chuah SK*. Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan. Therap Adv Gastroenterol. 2020 Dec 10;13:1756284820976990. (SCI)
      胃幽門螺旋桿菌抗藥性改變的趨勢 (2013-2019年): 台灣多中心的報告
    • Yang SC, Wu CK, Tai WC, Liang CM, Li YC, Yeh WS, Lee CH, Yang YH, Tsai TH, Hsu CN*, Chuah SK*. Incidence and risk factors of colonoscopic post-polypectomy bleeding and perforation in patients with end-stage renal disease. J Gastroenterol Hepatol. 2020 Oct;35(10):1704-1711. (SCI)
      末期腎臟病病人接受大腸鏡息肉切除術後出血和穿孔的發生率和危險因子
    • Wu CK, Yang SC, Liang CM, Li YC, Yeh WS, Tai WC, Lee CH, Yang YH, Hsu CN*, Tsai TH, Chuah SK*. The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. J Gastroenterol Hepatol. 2020 May;35(5):777-787.(SCI)
      代償性肝硬化病人併發上消化道出血經內視鏡止血治療後預防性抗生素的角色
    • Liang CM, Yang SC, Wu CK, Li YC, Yeh WS, Tai WC, Lee CH, Yang YH, Tsai TH, Hsu CN*, Chuah SK*. Risk of Recurrent Peptic Ulcer Disease in Patients Receiving Cumulative Defined Daily Dose of Nonsteroidal Anti-Inflammatory Drugs. J Clin Med. 2019 Oct; 8(10): 1722. (SCI)
      累積暴露量非類固醇止痛藥劑的使用導致消化性潰瘍疾病復發之危險因子
    • Tai WC, Liang CM, Bi KW, Kuo CM*, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF, Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK*. A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth. Infect Drug Resist. 2019 Sep 16;12:2923-2931. (SCI)
      比較以DEXLANSOPRAZOLE MR和以LANSOPRAZOLE為基礎不含鉍劑四合一幽門螺旋桿菌第一線治療之效益:一前瞻性研究比較
    • Tai WC, Liang CM, Kuo CM, Huang PY, Wu CK, Yang SC, Kuo YH, Lin MT, Lee CH, Hsu CN, Wu KL, Hu TH, Chuah SK*. A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial. J Antimicrob Chemother. 2019 Jun 1;74(6):1718-1724. (SCI)
      十四天含 esomeprazole及 amoxicillin「高劑量二合療法」在第一線幽門螺旋桿菌除菌治療可以達到高療效: 隨機試驗報告
    • Chuah SK, Lim CS, Liang CM, Lu HI,Wu KL,Changchien CS, Tai WC*. Bridging the Gap between Advancements in the Evolution of Diagnosis and Treatment towards Better Outcomes in Achalasia. Biomed Res Int. 2019 Feb 6;2019:8549187. (SCI) Review
      下食道弛緩不能症之診斷與治療新進展：邁向最佳化療效的橋樑
    • Huang PY, Tsai KL, Liang CM, Tai WC, Rau KM, Wu KL, Huang CC, Chuah SK*. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms. Kaohsiung J Med Sci. 2018 Nov;34(11):650-656. (SCI)
      腸胃胰神經內分泌腫瘤的臨床特徵及預後分析
    • Wang JW, Tseng KL, Hsu CN, Liang CM, Tai WC, Ku MK, Hung TH, Yuan LT, Nguang SH, Yang SC, Wu CK, Chiu CH, Tsai KL, Chang MW, Huang CF, Hsu PI, Wu DC*, Chuah SK*. Association between Helicobacter pylori eradication and the risk of coronary heart diseases. PLoS One. 2018 Jan 2;13(1):e0190219. (SCI)
      胃幽門螺旋桿菌的根除對於冠狀動脈疾病風險的相關性
    • Liang CM, Chiu CH, Wang HM, Tai WC, Yao CC,Tsai CE, Kuo CM, Chiu YC, Wu KL, Lee CH*, Tsai KL, Huang CF, Chuah SK*. First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan. Biomed Res Int. 2017;2017:3762194. (SCI)
      台灣慢性腎病患者感染胃幽門螺旋桿菌的第一線藥物治療
    • Liang CM(co-first), Kuo MT(co-first), Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK*, Taiwan Acid-Related Disease Study Group. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol. 2017 Dec 21; 23(47): 8395-8404. (SCI)
      針對胃食道逆流疾病 A 和B 級使用 DEXLANSOPRAZOLE 60 MG AND ESOMEPRAZOLE 40 MG 第一週治療的臨床反應
    • Hung TH, Liang CM, Hsu CN, Tai WC, Tsai KL, Ku MK, Wang JW, Tseng KL, Yuan LT, Nguang SH, Yang SC, Wu CK, Hsu PI, Wu DC*, Chuah SK*. Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan. PLoS One. 2017 Jul 24;12(7):e0181858. (SCI)
      肝硬化合併併發症和發生肝癌風險的相關性
    • Yang SC, Hsu CN, Liang CM, Tai WC, Wu CK, Shih CW, Ku MK, Yuan LT, Wang JW, Tseng KL, Hung TH, Nguang SH, Hsu PI, Wu DC, Chuah SK*. Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.PLoS One. 2017 Jan 12;12(1):e0168918. (SCI)
      影響肝硬化病人消化性潰瘍出血治療後再出血和死亡的危險因子-12年全國性世代研究
    • Wang JW, Hsu CN, Tai WC, Ku MK, Hung TH, Tseng KL, Yuan LT, Nguang SH, Liang CM, Yang SC, Wu CK, Hsu PI, Wu DC*, Chuah SK*. The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases. PLoS One. 2016 Oct 20;11(10):e0164824. (SCI)

    • Liang CM, Hsu CN, Tai WC, Yang SC, Wu CK, Shih CW, Ku MK, Yuan LT, Wang JW, Tseng KL, Sun WC, Hung TH, Nguang SH, Hsu PI, Wu DC*, Chuah SK*; Taiwan Acid-Related Disease (TARD) Study Group.Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study. Medicine (Baltimore). 2016 Sep;95(36):e4795. (SCI)
      影響慢性腎臟病患消化性潰瘍出血預後的因子-全國性世代研究
    • Liu CL(co-first), Wu CK*(co-first), Shi HY, Tai WC, Liang CM, Yang SC, Wu KL, Chiu YC, Chuah SK*. Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study. Medicine (Baltimore). 2016 Jul;95(28):e4215. (SCI)
      肝硬化食道靜脈曲張出血病人醫療資源耗用之探討-全國性世代研究
    • Chuah SK(co-first), Liang CM(co-first), Lee CH, Chiou SS, Chiu YC, Hu ML, Wu KL, Lu LS, Chou YP, Chang KC, Kuo CH, Kuo CM, Hu TH, Tai WC*. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication. Medicine (Baltimore). 2016 May;95(19):e3586. (SCI)
      比較兩種以LEVOFLOXACIN為基礎的幽門螺旋桿菌第二線治療之效益：隨機對照研究
    • Wang HM, Tai WC, Chuah SK*, Lu HI, Lu LS, Liang CM, Kuo CH, Chiu YC, Wu KL, Changchien CS. Comparison of treatment outcomes of endoscope-guided pneumatic dilation and laparoscopic Heller myotomy. Kaohsiung J Med Sci. 2015 Dec;31(12):639-43. (SCI)
      比較經由內視鏡引導執行氣球擴張術和外科微創手術治療下食道弛緩不能症病患的成效
    • Hsu PI, Lu CL, Wu DC, Kuo CH, Kao SS, Chang CC, Tai WC, Lai KH, Chen WC, Wang HM, Cheng JS, Tsai TJ, Chuah SK*. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with los angeles grade a or B erosive esophagitis. Clin Gastroenterol Hepatol. 2015 May;13(5):859-866. (SCI)

    • Tai WC, Liang CM(co-first), Lee CH, Chiu CH, Hu ML, Lu LS, Kuo YH, Kuo CM, Yen YH, Kuo CH, Chiou SS, Wu KL, Chiu YC, Hu TH, Chuah SK*. Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A” Success Rate for First-Line Helicobacter pylori Eradication. Biomed Res Int. 2015 Jan;2015:623732. (SCI)

    • Chuah SK*, Wu DC, Suzuki H, Goh KL, Kao J, Ren JL. Peptic ulcer diseases: genetics, mechanism, and therapies. Biomed Res Int. 2014;2014:898349. Editorial (SCI)
      消化性潰瘍疾病: 基因, 致病機轉及治療
    • Wang JH*, Chuah SK(co-first), Lu SN, Hung CH, Kuo CM, Tai WC, Chiou SS. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver Int. 2014 Oct;34(9):1340-8. (SCI)
      初次及連續的肝彈性度檢查對代償肝硬化病人門脈高壓進展的預測
    • Chuah SK, Tai WC(co-first), Lee CH*, Liang CM, Hu TH. Quinolone-Containing Therapies in the Eradication of Helicobacter pylori. BioMed Research International. 2014 Aug.; 2014 (2014): 151543. Review (SCI)
      含QUINOLONE之幽門螺旋桿菌除菌治療
    • Tai WC, Lee CH, Chiou SS, Kuo CM, Kuo CH, Liang CM, Lu LS, Chiu CH, Wu KL, Chiu YC, Hu TH, Chuah SK*. The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication. PLoS One. 2014 Aug 20;9(8):e105822. (SCI)

    • Yang SC, Chen JC(co-first), Tai WC, Wu CK, Lee CH, Wu KL, Chiu YC, Wang JH, Lu SN, Chuah SK*. The influential roles of antibiotics prophylaxis in cirrhotic patients with peptic ulcer bleeding after initial endoscopic treatments. PLoS One. 2014 May 2;9(5):e96394. (SCI)

    • Tai WC, Chiu CH (co-first), Liang CM, Chang KC, Kuo CM, Chiu YC, Wu KL, Hu ML, Chou YP, Chiou SS, Chiu KW, Kuo CH, Lin MT, Hu TH, Chuah SK*. Ten-day versus 14-day Levofloxacin-containing Triple Therapy for Second-line anti-Helicobacter Pylori Eradication in Taiwan. Gastroenterol Res Pract. 2013;2013:932478. (SCI)

    • Yew KC, Chuah SK*. Antireflux endoluminal therapies: past and present. Gastroenterol Res Pract. 2013;2013:481417. (SCI)

    • Chuah SK, Chiu CH, Tai WC, Lee JH, Lu HI, Changchien CS, Tseng PH, Wu KL*. Current status in the treatment options for esophageal achalasia. World J Gastroenterol. 2013 Sep 7;19(33):5421-9. (SCI)
      下食道弛緩不能症治療的最新發展
    • Wu CK, Wang JH, Lee CH, Wu KL, Tai WC, Lu SN, Hu TH, Chuah SK*. The outcome of prophylactic intravenous cefazolin and ceftriaxone in cirrhotic patients at different clinical stages of disease after endoscopic interventions for acute variceal hemorrhage. PLoS One. 2013 Apr 22;8(4):e61666. (SCI)

    • Yang SC, Wu KL, Wang JH, Lee CH, Kuo YH, Tai WC, Chen CH, Chiou SS, Lu SN, Hu TH, Changchien CS, Chuah SK*. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions. Hepatol Int. 2013 Mar;7(1):257-267. (SCI)
      肝硬化病人合併急性潰瘍出血,在接受內視鏡治療後投予預防性抗生素的效果
    • Chuah SK*, Tai WC, Hsu PI, Wu DC, Wu KL, Kuo CM, Chiu YC, Hu ML, Chou YP, Kuo YH, Liang CM, Chiu KW, Hu TH. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study. Helicobacter. 2012 Oct;17(5):374-81. (SCI)

    • Lin SC, Wu KL, Chiu KW, Lee CT, Chiu YC, Chou YP, Hu ML, Tai WC, Chiou SS, Hu TH, Changchien CS, Chuah SK*. Risk factors influencing the outcome of peptic ulcer bleeding in end stage renal diseases after initial endoscopic haemostasis. Int J Clin Pract. 2012 Aug;66(8):774-781. (SCI)

    • Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS*, Wu DC, Hu TH. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter. 2012 Jun;17(3):216-23. (SCI)

    • Chiu YC, Lu LS, Wu KL, Tam W, Hu ML, Tai WC, Chiu KW, Chuah SK*. Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage. BMC Gastroenterol. 2012 Jun 9;12:67. (SCI)

    • Chuah SK, Hsu PI, Wu KL*, Wu DC, Tai WC, Changchien CS. 2011 update on esophageal achalasia. World J Gastroenterol. 2012 Apr 14;18(14):1573-8. (SCI)

    • Liang CM, Lee JH (co-first), Kuo YH, Wu KL, Chiu YC, Chou YP, Hu ML, Tai WC, Chiu KW, Hu TH, Chuah SK*. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis. BMC Gastroenterol. 2012 Mar 28;12:28. (SCI)

    • Chuah SK, Wu KL*, Tai WC, Changchien CS. The effects of ginger on gallbladder motility in healthy male humans. J Neurogastroenterol Motil. 2011 Oct;17(4):411-5.

    • Chuah SK, Tsay FW, Hsu PI*, Wu DC. A new look at anti-Helicobacter pylori therapy. World J Gastroenterol. 2011 Sep 21;17(35):3971-5. (SCI)

    • Xu HW, Wang JH, Tsai MS, Wu KL, Chiou SS, Changchien CS, Hu TH, Lu SN, Chuah SK*. The effects of cefazolin on cirrhotic patients with acute variceal hemorrhage after endoscopic interventions. Surg Endosc. 2011 Sep;25(9):2911-8. (SCI)

    • Chen CH, Chiu YC, Chou YP, Kuo CM, Wu KL, Chuah SK*. Cronkhite-Canada Syndrome: Report of a Case. Gastroenterol J Taiwan. 2011 Mar;28(1):57-61.

    • Hu ML, Wu KL, Chiu KW, Chiu YC, Chou YP, Tai WC, Hu TH, Chiou SS, Chuah SK*. Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers. World J Gastroenterol. 2010 Nov 21;16(43):5490-5. (SCI)

    • Tai WC, Hu TH, Lee CH, Chen HH, Huang CC, Chuah SK*. Ano-perianal tuberculosis: 15 years of clinical experiences in Southern Taiwan. Colorectal Dis. 2010 Jul;12(7 Online):e114-20. (SCI)

    • Chuah SK, Wu KL, Hu TH, Tai WC, Changchien CS*. Endoscope-guided pneumatic dilation for treatment of esophageal achalasia. World J Gastroenterol. 2010 Jan 28;16(4):411-7. Review. (SCI)

    • Hu ML, Lee CH, Kuo CM, Huang CC, Tai WC, Chang KC, Lee CM, Chuah SK*. Abdominal tuberculosis: analysis of clinical features and outcome of adult patients in southern Taiwan. Chang Gung Med J. 2009 Sep-Oct;32(5):509-16.

    • Lin MT, Tai WC, Chiu KW, Chou YP, Tsai MC, Hu TH, Lee CM, Changchien CS, Chuah SK*. Delayed presentation of intrathoracic esophageal perforation after pneumatic dilation for achalasia. World J Gastroenterol. 2009 Sep 21;15(35):4461-3. Review. (SCI)

    • Tai WC, Changchien CS, Hu TH, Huang CC, Chuah SK*, Lee CM. Pancreatic head cancer with distant duodenal metastasis: a case report with rare endoscopic presentations. Am J Med Sci. 2009 Jul;338(1):75-7. (SCI)

    • Chuah SK, Hu TH, Wu KL, Chen TY, Changchien CS*, Lee CM. The role of barium esophagogram measurements in assessing achalasia patients after endoscope-guided pneumatic dilation. Dis Esophagus. 2009;22(2):163-8. (SCI)

    • Chuah SK, Hu TH, Wu KL, Hsu PI, Tai WC, Chiu YC, Lee CM, Changchien CS*. Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation. J Gastrointest Surg. 2009 May;13(5):862-7. (SCI)

    • Chuah SK, Hu TH, Wu KL, Tai WC, Chen TY, Chiu YC, Hu ML, Changchien CS*, Lee CM. Sonographic findings in esophageal achalasia. Chang Gung Med J. 2009 Mar-Apr;32(2):204-11.

    • Tai WC, Kuo CM, Lee CH, Chuah SK*, Huang CC, Hu TH, Wang JH, Chang KC, Tseng PL, Changchien CS, and Lee CM. Liver Tuberculosis in Southern Taiwan：15-years Clinical Experience . J Intern Med Taiwan 2008 Oct; 19(5): 410-417.

    • Kuo CM, Hu TH, Kuo CH, Luo YL, Lee CH, Huang CC, Changchien CS, Chuah SK*. Pseudomembranous colitis : A clinical report from southern Taiwan. J Intern Med Taiwan 2008 June; 19(3): 253-259.

    • Chen CH, Kuo Cm, Hu TH, Chuah SK*, Changchien CS. Colon Cytomegalovirus Infection：A Case Report With Rare Endoscopic Presentations. J Intern Med Taiwan 2008 Feb.; 19(1):67-71.

    • Chuah SK, Hu TH, Wu KL, Kuo CM, Fong TV, Lee CM, Changchien CS*. Endoscope-guided pneumatic dilatation of esophageal achalasia without fluoroscopy is another safe and effective treatment option: a report of Taiwan. Surg Laparosc Endosc Percutan Tech. 2008 Feb;18(1):8-12. (SCI)